Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?-Reference-Cited by-同舟云学术

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

Published:2020-10-08 Issue: Volume: Page:m3841
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Sarpatwari Ameet,Avorn Jerry,Kesselheim Aaron S

Publisher

BMJ

Subject

General Engineering

Reference35 articles.

1. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

2. The high price of anticancer drugs: origins, implications, barriers, solutions

3. Ornstein C, Thomas K. Prescription drugs may cost more with insurance than without it. New York Times 2017 Dec 9. https://www.nytimes.com/2017/12/09/health/drug-prices-generics-insurance.html

4. Herman B. Americans are still struggling with drug costs. Axios, 26 Nov 2018. https://www.axios.com/americans-struggling-drug-costs-goodrx-0b487b1b-a362-4776-8f43-8b118651d606.html

5. PhRMA. Advocacy: research and development. https://www.phrma.org/advocacy/research-development

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study;BMJ;2023-03-01

2. Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports;Cost Effectiveness and Resource Allocation;2022-08-31

3. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms;Journal of Health Politics, Policy and Law;2022-07-14

4. The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies;PLOS ONE;2021-10-22

5. Discovery and Development of Pregabalin (Lyrica);Neurology;2021-09-07